Is Entheon Biomedical Corp. (ENBI.CN) a Buy, Sell, or Hold?
Entheon Biomedical Corp.
CNQ:ENBI.CN
$0.1 CAD
$0 (0.0%)
- Volume
- 4K
- Average Volume
- 8.9K
- Market Capitalization
- $1.39M
- P/E Ratio
- -4.00
- Dividend Yield
- 0.00%
- Price Target
- $
- Year High
- $0.45
- Year Low
- $0.07
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $11.72
Industry, Sector & symbol
| Stock Exchange | CNQ |
| CEO | Timothy Ko |
| Industry | Biotechnology |
| Sector | Healthcare |
| Current Symbol | ENBI.CN |
| CUSIP | None |
| CIK | None |
| Web | https://www.entheonbiomedical.com |
| Phone | 604-562-3932 |
| Currency | CAD |
| Employees | 1 |
| Country | CA |
Liquidity
| Debt-to-Equity Ratio | 0.00 |
| Payout Ratio | 0.00 |
| Current Ratio | 11.72 |
| Quick Ratio | 11.72 |
| Cash Ratio | 10.82 |
Sales & Book Value
| Annual Sales | $- |
| Price / Sales | 0.00 |
| Cash Flow | -0.02 |
| Price / Cash Flow | -4.40 |
| Price / Book | 4.28 |
Price Target and Rating
| Average Stock Price Forecast | $ |
| High Stock Price Forecast | $ |
| Low Stock Price Forecast | $ |
| Forecast Upside/Downside | % |
| Consensus Rating | N/A |
| Rating Score(0-5) | 0 |
| Research Coverage | 0 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $-0.0242 |
| Trailing P/E Ratio | -4.00 |
| PEG Ratio | -0.07 |
| P/E Growth | -0.07 |
| Net Income | $-324.01K |
| Net Margin | 0.00% |
| Pretax Margin | 0.00% |
| Return on Equity | -78.74% |
| Return on Assets | -91.75% |
Financials Score
| AltmanZ Score | -58.70 |
| Piotroski Score | 2.00 |
| Working Capital | 319.03K |
| Total Assets | 353.78K |
| Ebit | -549.41K |
| Market Cap | 1.39M |
| Total Liabilities | 29.75K |
Poll Results
About Entheon Biomedical Corp. (CNQ:ENBI.CN) Stock
Entheon Biomedical Corp. functions as a biotechnology firm focused on the research and development of novel pharmaceuticals. The company is actively involved in pioneering and introducing to market psychedelic therapeutic products, specifically those derived from N,N-dimethyltryptamine (DMT), with the aim of combating addiction and various substance use disorders. Its services are provided to medical doctors, healthcare facilities, and accredited psychiatrists across Canada, the United States, and the European Union. Entheon Biomedical Corp.'s primary operations are based in Vancouver, Canada. ...
Frequently Asked Questions
-
What is the current Entheon Biomedical Corp. (ENBI.CN) stock price?
-
Entheon Biomedical Corp.(CNQ:ENBI.CN) stock price is $0.1 in the last trading session. During the trading session, ENBI.CN stock reached the peak price of $0.45 while $0.07 was the lowest point it dropped to. The percentage change in ENBI.CN stock occurred in the recent session was 0.0% while the dollar amount for the price change in ENBI.CN stock was $0.
-
ENBI.CN's industry and sector of operation?
-
The CNQ listed ENBI.CN is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of ENBI.CN?
-
Soo-Whan Kim | Interim Chief Financial Officer
Timothy Ko | President, CEO, Corporate Secretary & Director
Brian E. Jahns | Chief Business Officer
|
| -
How many employees does ENBI.CN have?
-
Number of ENBI.CN employees currently stands at 1. ENBI.CN operates from 999 West Broadway, Vancouver, BC V5Z 1K5, CA.
-
Link for ENBI.CN official website?
-
Official Website of ENBI.CN is: https://www.entheonbiomedical.com
-
How do I contact ENBI.CN?
-
ENBI.CN could be contacted at phone #604-562-3932 and can also be accessed through its website. ENBI.CN operates from 999 West Broadway, Vancouver, BC V5Z 1K5, CA.
-
How many shares of ENBI.CN are traded daily?
-
The average number of ENBI.CN shares traded daily for last 3 months was 8.9K.
-
What is the market cap of ENBI.CN currently?
-
The market value of ENBI.CN currently stands at $1.39M with its latest stock price at $0.1